30.4 C
New York
Wednesday, July 28, 2021

EU seals 2nd COVID-19 vaccine deal as deadline for WHO scheme looms

Must read

Saúde vai analisar antecipação da 2ª dose após aplicação da 1ª em adultos

O Ministério da Saúde informou na noite desta terça-feira que deve analisar a antecipação da segunda dose das vacinas contra covid-19 somente...

Prominent US Democratic Party activist convicted in ‘party and play’ deaths

Sports & General28 minutes ago (Jul 27, 2021 08:16PM ET) 2/2 (C) Reuters. FILE PHOTO: Ed Buck, 56, arrives for a campaign rally in Hollywood, California,...

Unidas reverte prejuízo e registra lucro de R$ 239,5 milhões no 2º tri

A Companhia de Locação das Américas (Unidas) registrou no segundo trimestre um lucro líquido de R$ 239,5 milhões, revertendo o prejuízo de...

Bolsonaro diz que Ramos tinha dificuldade com “linguajar” do Congresso

O presidente Jair Bolsonaro afirmou hoje que a escolha do senador Ciro Nogueira (PP-PI), líder do Centrão, para a Casa Civil levou...
imageCoronavirus8 minutes ago (Sep 18, 2020 06:35AM ET)

(C) Reuters. FILE PHOTO: Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration

By Philip Blenkinsop and Matthias Blamont

BRUSSELS/PARIS (Reuters) – The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi (NASDAQ:SNY) and GSK in its second such deal to secure supplies, as a deadline for joining the World Health Organization’s (WHO) vaccine purchase programme looms.

The deal will see the French and British drugmakers, which have teamed up to manufacture a recombinant protein-based vaccine they hope to get approved next year, provide the EU with up to 300 million doses, according to a tweet from European Health Commissioner Stella Kyriakides.

Friday’s agreement confirms an announcement made on July 31 by the two companies and follows an earlier deal between the EU and AstraZeneca (NYSE:AZN) for up to 400 million shots.

In return for the right to the doses, the European Commission will finance part of the upfront costs faced by vaccine producers. The vaccine doses themselves will be bought by EU countries.

The latest deal comes on deadline day for members of the WHO to join its COVAX scheme, which aims to buy COVID-19 vaccines and ensure immunisations are then fairly and efficiently distributed.

So far, 92 lower-income nations are seeking assistance via COVAX, part of the WHO’s ACT Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic.

Some 80 higher-income nations have expressed interest, but many still have to join as they scramble to secure supplies separately.

France will provide funding for the initiative but will not source shots through it, an official at its health ministry said on Thursday, after Paris decided to be part of a joint scheme arranged through the EU.

There is currently no internationally-approved vaccine for COVID-19, the illness caused by the new coronavirus, which has claimed more than 946,000 lives globally and derailed the world economy.

For Sanofi and GSK, the deal follows a $2.1 billion agreement with the United States in July for 100 million doses, with an option for the U.S. government to purchase an additional 500 million, as well as a deal to deliver 60 million doses to the United Kingdom.

EU seals 2nd COVID-19 vaccine deal as deadline for WHO scheme looms

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

Saúde vai analisar antecipação da 2ª dose após aplicação da 1ª em adultos

O Ministério da Saúde informou na noite desta terça-feira que deve analisar a antecipação da segunda dose das vacinas contra covid-19 somente...

Prominent US Democratic Party activist convicted in ‘party and play’ deaths

Sports & General28 minutes ago (Jul 27, 2021 08:16PM ET) 2/2 (C) Reuters. FILE PHOTO: Ed Buck, 56, arrives for a campaign rally in Hollywood, California,...

Unidas reverte prejuízo e registra lucro de R$ 239,5 milhões no 2º tri

A Companhia de Locação das Américas (Unidas) registrou no segundo trimestre um lucro líquido de R$ 239,5 milhões, revertendo o prejuízo de...

Bolsonaro diz que Ramos tinha dificuldade com “linguajar” do Congresso

O presidente Jair Bolsonaro afirmou hoje que a escolha do senador Ciro Nogueira (PP-PI), líder do Centrão, para a Casa Civil levou...

Biden adverte que ataques cibernéticos podem provocar “guerra real”

Mundiais49 minutos atrás (27.07.2021 20:56) © Reuters. Presidente dos EUA Joe Biden 27/7/2021 REUTERS/Evelyn Hockstein Por Nandita Bose WASHINGTON (Reuters) - O presidente dos Estados Unidos, Joe...